(Q34167137)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

A microRNA survival signature (MiSS) for advanced ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

9

Richard R Barakat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Karin K Shih

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Li-Xuan Qin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Qin Zhou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Maria Bisogna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Fanny Dao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Narciso Olvera

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Agnes Viale

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Douglas A Levine

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

English

0 references

publication date

26 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

444-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

Ovarian cancer: epidemiology, biology, and prognostic factors

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Gene expression signature with independent prognostic significance in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Identification of hundreds of conserved and nonconserved human microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Oncomirs - microRNAs with a role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

MicroRNA signatures in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

MicroRNA expression profiles in serous ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Endogenous human microRNAs that suppress breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Prediction of mammalian microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Prediction and validation of microRNA targets in animal genomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Prediction of microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

microRNA target predictions in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Nuclear factor kappa B--molecular biomedicine: the next generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.025

10.1016/J.YGYNO.2011.01.025

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21354599%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference